Should You Buy Automation Company UiPath Following the Stock’s More than 70% Drop

Shares of UiPath Inc. (PATH) are down more than 35% in price over the past month. Although rising demand for robotic process automation has increased PATH’s sales, the question is,…

Is Pacific Biosciences of California a Winner in the Diagnostics & Research Industry?

Despite posting robust sales growth in its last quarter, Pacific Biosciences (PACB) failed to meet consensus sales estimates. In addition, the company continues to face severe headwinds in the guise…